Clinical Trials Browser

Phase 4 × Refractory Solid Tumors × Sirolimus × Clear all

NCT02688881 2022-06-15

Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

Phase 4 Completed

Other solid neoplasm

Refractory Solid Tumors